The early impact of human papillomavirus vaccination on anogenital warts in Québec, Canada
M Steben, N Ouhoummane, C Rodier… - Journal of Medical …, 2018 - Wiley Online Library
In Québec province in Canada, a public school‐based and catch‐up HPV vaccination
programs with the quadrivalent vaccine have been introduced in September 2008 for girls …
programs with the quadrivalent vaccine have been introduced in September 2008 for girls …
[HTML][HTML] The quadrivalent HPV vaccine is protective against genital warts: a meta-analysis
Background The quadrivalent human papillomavirus (HPV) vaccine has been assumed to
give protection against genital warts (GW) as well as cervical cancer. Our main question was …
give protection against genital warts (GW) as well as cervical cancer. Our main question was …
Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV‐related disease in females and males
H Bergman, BS Buckley, G Villanueva… - Cochrane database …, 1996 - cochranelibrary.com
Background Uptake of human papillomavirus (HPV) vaccine remains low in many countries,
although the bivalent and quadrivalent HPV vaccines given as a three‐dose schedule are …
although the bivalent and quadrivalent HPV vaccines given as a three‐dose schedule are …
2019 IUSTI‐Europe guideline for the management of anogenital warts
R Gilson, D Nugent, RN Werner… - Journal of the …, 2020 - Wiley Online Library
This guideline is an update of the 2011 European Guideline for the Management of
Anogenital Warts. It is intended to support best practice in the care of patients with …
Anogenital Warts. It is intended to support best practice in the care of patients with …
[HTML][HTML] Quadrivalent HPV vaccine effectiveness against anogenital warts: A registry-based study of 2, 2 million individuals
Abstract Background In 2009, Norway initiated routine quadrivalent HPV (qHPV) vaccination
for girls at 12–13 years of age to protect against virus types causing cervical cancer …
for girls at 12–13 years of age to protect against virus types causing cervical cancer …
[HTML][HTML] The effectiveness of HPV vaccination on the incidence of oropharyngeal cancers in men: a review
P Macilwraith, E Malsem, S Dushyanthen - Infectious Agents and Cancer, 2023 - Springer
Abstract Background Human Papilloma Virus (HPV) contributes to the development of
oropharyngeal cancer (OPC) and is currently the leading cause of OPC in the Western …
oropharyngeal cancer (OPC) and is currently the leading cause of OPC in the Western …
[HTML][HTML] Genital Warts in Women Vaccinated against HPV in Childhood: A Systematic Review
R Malheiro, C Magalhães, CC Dias, AG Rodrigues… - Vaccines, 2024 - mdpi.com
Human papillomavirus (HPV) is the most prevalent sexually transmitted infection among
young women. Notably, more than ten years after the introduction of HPV vaccination …
young women. Notably, more than ten years after the introduction of HPV vaccination …
Genital warts
M Steben, SM Garland - Best practice & research Clinical obstetrics & …, 2014 - Elsevier
Anogenital warts (AGWs) are a very common disease. They are caused mostly by low-risk
human papillomaviruses (HPV) 6 and 11, particularly the former. Clinical presentation is …
human papillomaviruses (HPV) 6 and 11, particularly the former. Clinical presentation is …
[引用][C] Benefits and harms of the human papillomavirus (HPV) vaccines: Systematic review with meta-analyses of trial data from clinical study reports
L Jorgensen, PC Gotzsche… - SYSTEMATIC …, 2020 - … , 4 CRINAN ST, LONDON N1 9XW …
[HTML][HTML] Summary of the evidence on the safety, efficacy, and effectiveness of human papillomavirus vaccines: Umbrella review of systematic reviews
Background This objective of this umbrella review was to summarize the evidence on safety,
efficacy, and effectiveness of human papillomavirus (HPV) vaccines in the general …
efficacy, and effectiveness of human papillomavirus (HPV) vaccines in the general …